Stellantis is looking to bring €190 billion in revenue from 2030, compared to €154 billion reported in 2025.
Stocktwits
More News
Shell Stock Hits 52-Week High – Here’s Why
Rise in oil prices amid the ongoing conflict in the middle-east has spiked Brent crude and other energy product prices.
Stocktwits
Novo Nordisk To Launch Ozempic Pills Following Flat Growth In Diabetes Segment In 2025
The Ozempic pill will be launched in Q2 2026 and be available in doses 1.5 mg, 4 mg, and 9 mg.
Stocktwits
Novo Nordisk Shares Tumble On 2025 Earnings Miss, Weak Sales Forecast And Competition Concerns
The drugmaker now expects fiscal 2026 adjusted sales down 5% to 13%.
Stocktwits
Why Bitfarms Stock Is Down After Hours?
Keefe Bruyette downgraded Bitfarms to ‘Market Perform’ from ‘Outperform’.
Stocktwits
Novo Nordisk In Green After Oral Wegovy Clocks Over 18K Prescriptions In A Week
Reuters reported on Friday, citing IQVIA data shared by analysts, that Novo’s weight-loss pill was prescribed 18,410 times in the week ended January 16.
Stocktwits
BHC Stock Plummets On Failed Liver Cirrhosis Trial: Retail Says ‘Lost Battle But Not The War’
The failed clinical program evaluated rifaximin SSD for the delay of the first episode of hepatic encephalopathy (HE) in adults with liver cirrhosis who experienced no prior episodes.
Stocktwits
Novo Nordisk Inks Deal With Canada’s Aspect Biosystems To Find More Diabetes Meds Besides Ozempic
Novo and Aspect have been collaborating since 2023 to develop cellular medicines, and said that the new partnership phase builds on the momentum achieved in the existing collaboration.
Stocktwits
Genmab Stock Drops On Mixed Results From Late-Stage Trial Of Lymphoma Drug
Epcoritamab demonstrated an improvement in progression-free survival in certain patients with relapsed or refractory diffuse large B-cell lymphoma, the company said.
Stocktwits
NVS Stock Rises After FDA Grants Breakthrough Therapy Designation For Autoimmune Disorder Treatment
Novartis looks to submit data from its many trials of Ianalumab with health authorities starting in early 2026 for potential approval.